ReviewJournal of clinical medicine2022

Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis.

Luca Massacesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.